Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

Lead Sponsor:

Liga Panamericana de Asociaciones de Reumatologia (PANLAR)

Conditions:

Arthritis, Rheumatoid

Arthritis, Psoriatic

Eligibility:

All Genders

18+ years

Brief Summary

This prospective, non-interventional, research registry is designed to study the comparative safety and comparative effectiveness of approved Jak Inhibitors treatment for RA-PsA-SpA in a cohort of pat...

Detailed Description

There is scarce data on the real-world safety and effectiveness of Jak in Latin America. This registry will provide reliable data on the use of JAKi in LA, as will be a prospective study involving car...

Eligibility Criteria

Inclusion

  • To be eligible for enrollment into the PREJAK Registry, a patient must satisfy all of the inclusion criteria and none of the exclusion criteria listed below.
  • Inclusion Criteria
  • The patient must be:
  • One of the following:
  • Diagnosis with rheumatoid arthritis (RA) and initiating (prescribed or starting) a Januse Kinase inhibitors (JAKi) for the treatment of RA at the enrollment visit.
  • Meet the ASAS criteria for axial spondyloarthritis (AxSpA), including radiographic or non-radiographic, and initiating (prescribe or starting) a JAKi for the treatment of AxSpA at the enrollment visit.
  • Diagnosis with psoriatic arthritis (PsA) and initiating (prescribed or starting) a Januse Kinase inhibitors (JAKi) for the treatment of PsA at the enrollment visit.
  • At least 18 years age or older
  • Able and willing to provide written consent
  • Exclusion Criteria:
  • Patients who do not wish to participate or are unable to give informed consent

Exclusion

    Key Trial Info

    Start Date :

    March 1 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 1 2024

    Estimated Enrollment :

    3000 Patients enrolled

    Trial Details

    Trial ID

    NCT04821206

    Start Date

    March 1 2021

    End Date

    July 1 2024

    Last Update

    March 29 2021

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Hospital Italiano de Buenos Aires

    CABA, Buenos Aires, Argentina, 1199

    2

    Nicolas Marin Zucaro

    Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina, 1425